Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-24Clinical Trial Update: Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLC [Phase 2]
Phase II study in elderly patients with IIIB/IV non-small cell lung cancer evaluating gemcitabine with erlotinib (and related regimens); res…
-
CLINICAL_TRIALS withdrawal · 2017-04-24Clinical Trial Update: Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction [Phase 1]
A Phase 1 clinical trial of talazoparib in patients with advanced or metastatic solid tumors unsuitable for surgery and with liver or kidney…
-
CLINICAL_TRIALS trial_result · 2017-04-21Clinical Trial Update: Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer [Phase 3]
This update reports on a Phase 3 study comparing bavituximab plus docetaxel versus docetaxel alone in late-stage non-squamous non-small cell…
-
CLINICAL_TRIALS research · 2017-04-21Clinical Trial Update: β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant NSCLC [Phase 2]
Phase 2 clinical trial evaluating the combination of beta-elemene with an EGFR-TKI in advanced EGFR-TKI–resistant non-small cell lung cancer…
-
CLINICAL_TRIALS research · 2017-04-21Clinical Trial Update: Endostar First-line Treatment of Advanced NSCLC [Phase 2]
Update on a Phase 2 trial of Endostar as first-line treatment for advanced non-small cell lung cancer; the current trial status is unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel/carboplatin with or without bavituximab in previously untreated non-small cell lung cancer has completed…
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer [Phase 2]
Phase 2 trial completion reported for a study of Bavituximab in combination with Docetaxel in locally advanced or metastatic non-squamous no…
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Early Changes in Positron Emissions Tomography (PET/CT) Scan as Predictors of Clinical Outcome in NSCLC Treated With EGFR Tyrosin Kinase Inhibitors (TKI) [NA]
A completed clinical trial investigates whether early changes on PET/CT scans can predict outcomes for non-small cell lung cancer patients t…
-
CLINICAL_TRIALS trial_result · 2017-04-17Clinical Trial Update: Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating recombinant endostatin in combination with vinorelbine and cisplatin in patients with advanced non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2017-04-14Clinical Trial Update: Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer [Phase 2]
This clinical trial update reports the completion of a Phase 2 dose-range study of anamorelin in patients with non-small cell lung cancer.
-
CLINICAL_TRIALS withdrawal · 2017-04-14Clinical Trial Update: DE-CT in Lung Cancer Proton Therapy [NA]
A clinical trial titled DE-CT in Lung Cancer Proton Therapy (NCT02844140) sponsored by Maastricht Radiation Oncology has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-04-14Clinical Trial Update: The Oncopanel Pilot (TOP) Study
The Oncopanel Pilot (TOP) Study status is listed as completed in this ClinicalTrials.gov update. The update enumerates several cancer indica…
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: A Study to Assess Biomarkers Impact on Participants Response to Erlotinib Treatment for First-line Non-Small Cell Lung Cancer With Endothelial Growth Factor Receptor (EGFR) Activating Mutations [Phase 2]
Phase 2 trial evaluating whether biomarkers influence response to Erlotinib as first-line therapy in EGFR-mutant non-small cell lung cancer,…
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer [Phase 2]
A Phase II trial of VS-6063 (defactinib) in KRAS-mutant non-small cell lung cancer has completed.
-
CLINICAL_TRIALS withdrawal · 2017-04-13Clinical Trial Update: Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation [NA]
The clinical trial evaluating pulmonary rehabilitation for improved lung function in locally advanced non-small cell lung cancer patients un…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib) [Phase 2]
Phase 2 trial evaluating tetracycline prophylaxis to prevent rash in non-small cell lung cancer patients treated with afatinib (BIBW2992); t…
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLC [Phase 2]
Phase 2 trial update examining erlotinib therapy and subsequent mechanisms of resistance in patients with non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED) [Phase 2]
A Phase 2 study of SAHA (vorinostat) in relapsed or refractory breast cancer, colorectal cancer, and non-small cell lung cancer was terminat…
-
CLINICAL_TRIALS research · 2017-04-07Clinical Trial Update: MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC [Phase 1]
Phase I study of MesomiR-1 (TargomiRs) for recurrent malignant pleural mesothelioma and non-small cell lung cancer; the trial status is comp…
-
CLINICAL_TRIALS research · 2017-04-06Clinical Trial Update: Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care [NA]
This completed clinical trial evaluated how well healthcare providers adhere to survivorship care guidelines for survivors of non-small cell…
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer [Phase 2]
A Phase 2 trial evaluated zoledronic acid (Zometa) for bone metastases in lung cancer (including non-small cell and small cell) and was term…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating whether positron emission tomography (PET) can predict response in stage I-III non-small cell lung cancer patients …
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial results for a vaccine therapy in patients with stage I–III non-small cell lung cancer have been posted.
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer [Phase 2]
Phase 2 trial update evaluating systemic and topical treatments to manage rash caused by erlotinib in non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2017-04-04Clinical Trial Update: Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC
A retrospective, multi-indication study sponsored by Optimata Ltd. to validate PrediCare's ability to predict Time To Progression in cancer …